Cited by 84Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and CancerImmune cells in cancer

Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target

Open access
Zhao, Junpeng, Jin, Dandan, Huang, Mengxiang, Ji, Jie, Xu, Xuebing, Wang, Fei, Zhou, Lirong, Bao, Baijun +4 more·2024·Frontiers in Cell and Developmental Biology

Abstract

Even with sufficient oxygen, tumor cells use glycolysis to obtain the energy and macromolecules they require to multiply, once thought to be a characteristic of tumor cells known as the “Warburg effect”. In fact, throughout the process of carcinogenesis, immune cells and stromal cells, two major cellular constituents of the tumor microenvironment (TME), also undergo thorough metabolic reprogramming, which is typified by increased glycolysis. In this review, we provide a full-scale review of the glycolytic remodeling of several types of TME cells and show how these TME cells behave in the acidic milieu created by glucose shortage and lactate accumulation as a result of increased tumor glycolysis. Notably, we provide an overview of putative targets and inhibitors of glycolysis along with the viability of using glycolysis inhibitors in combination with immunotherapy and chemotherapy. Understanding the glycolytic situations in diverse cells within the tumor immunological milieu will aid in the creation of subsequent treatment plans.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fcell.2024.1416472

Cites

165 of 165 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Glycolysis is a canonical hallmark of cancer metabolism and plays a pivotal role in tumor initiation, progression, and adaptation to microenvironmental stress.

    “Glycolysis constitutes a canonical hallmark of cancer metabolism and plays a pivotal role in tumor initiation, progression, and adaptation to microenvironmental stress (9).”

    From Bioinformatics-based identification of glycolysis-related signatures associated with drug resistance and prognosis in lung adenocarcinoma (2026) · cites this paper as [9]

    The Introduction (page unavailable) describes aerobic glycolysis as a characteristic of tumors and a crucial indicator of malignant transformation. Section 4 says enhanced glycolysis promotes tumor development, while Section 2.3.8 links it to the hypoxic tumor microenvironment. These passages support its role in cancer metabolism, progression, and response to microenvironmental stress, but do not establish a role in tumor initiation. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhao, J., Jin, D., Huang, M., Ji, J., Xu, X., Wang, F., Zhou, L., Bao, B., Jiang, F., Xu, W., Lu, X., & Xiao, M.
Affiliations
Nantong University (CN)
Corresponding author
  • Xu, Weisong
  • Lu, Xiaomin
  • Xiao, Mingbing
Venue
Frontiers in Cell and Developmental Biology
Published
2024-06-12
Volume
12
Pages
1416472-1416472
ISSN
2296-634X (ISSN-L)
OpenAlex
W4399592964
Cited by
84
References
165
Citations by year
2026: 38 · 2025: 42 · 2024: 4
FWCI
4.10
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Cell and Developmental Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (82272624, YJXYY202204)
  • Government of Jiangsu Province
  • Natural Science Foundation of Jiangsu Province (BK20211105)
  • Nantong University
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
glycolysis, tumor microenvironment, Warburg effect, metabolic reprogramming, tumor progression, tumor acidosis, lactate accumulation, tumor-infiltrating immune cells, tumor stromal cells, glycolysis inhibitors, combination therapy, immunotherapy, chemotherapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review